✦ LIBER ✦

Giant cell carcinoma of the lung

✍ Scribed by Steven S. Ginsberg; Antonio C. Buzaid; Harold Stern; Darvyl Carter

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 493 KB
Volume: 70
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19920801)70:3<606::aid-cncr2820700311>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy in oat cell car

Combination chemotherapy in oat cell carcinoma of the lung

✍ Dr. Daniel W. Nixon; Robert W. Carey; Herman D. Suit; Alan C. Aisenberg 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 2 views

Hemophagocytosis by small cell lung carc

Hemophagocytosis by small cell lung carcinoma

✍ Yair Molad; Pinhas Stark; Miron Prokocimer; Henry Joshua; Jack Pinkhas; Dr. Yech 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Doxorubicin—hexamethylmelamine therapy o

Doxorubicin—hexamethylmelamine therapy of small cell carcinoma of the lung

✍ Parvez Dara; Michael J. Schultz; Lewis M. Slater; Steven A. Armentrout 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

Composite carcinoma of the lung simulati

Composite carcinoma of the lung simulating small-cell carcinoma in a child

✍ Sirvent, Nicolas; Deville, Anne; Keita, Olivia; Michiels, Jean-Fran�ois; Valla, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

× 360).

Patterns of angiogenesis in nonsmall-cel

Patterns of angiogenesis in nonsmall-cell lung carcinoma

✍ Birgitte V. Offersen; Per Pfeiffer; Stephen Hamilton-Dutoit; Jens Overgaard 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Combination chemotherapy of advanced non

Combination chemotherapy of advanced non-oat cell carcinoma of the lung

✍ Frederick Richards II; Douglas R. White; Hyman B. Muss; Don V. Jackson; John J. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

A controlled clinical trial comparing combination chemotherapy was performed in 147 patients with advanced inoperable non-oat cell bronchogenic carcinoma. All patients were stratified according to cell type, performance status, and extent of disease. They were then randomized to one of two combinati